Related references
Note: Only part of the references are listed.Pharmacokinetic considerations on the repurposing of ivermectin for treatment of COVID-19
Ricardo Pena-Silva et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2021)
Antivirals that target the host IMPα/β1-virus interface
Alexander J. Martin et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2021)
An in-silico study on selected organosulfur compounds as potential drugs for SARS-CoV-2 infection via binding multiple drug targets
Liya Thurakkal et al.
CHEMICAL PHYSICS LETTERS (2021)
A systematic review of experimental evidence for antiviral effects of ivermectin and an in silico analysis of ivermectin's possible mode of action against SARS-CoV-2
Robert T. Kinobe et al.
FUNDAMENTAL & CLINICAL PHARMACOLOGY (2021)
Exploration of inhibitory action of Azo imidazole derivatives against COVID-19 main protease (Mpro): A computational study
Abhijit Chhetri et al.
JOURNAL OF MOLECULAR STRUCTURE (2021)
Molecular Docking Reveals Ivermectin and Remdesivir as Potential Repurposed Drugs Against SARS-CoV-2
Ahmad F. Eweas et al.
FRONTIERS IN MICROBIOLOGY (2021)
Identification of 3-chymotrypsin like protease (3CLPro) inhibitors as potential anti-SARS-CoV-2 agents
Vicky Mody et al.
COMMUNICATIONS BIOLOGY (2021)
DFT, molecular docking and molecular dynamics simulation studies on some newly introduced natural products for their potential use against SARS-CoV-2
Taner Erdogan
JOURNAL OF MOLECULAR STRUCTURE (2021)
Protein-complex stability in cells and in vitro under crowded conditions
Samantha S. Stadmiller et al.
CURRENT OPINION IN STRUCTURAL BIOLOGY (2021)
Pharmacoinformatics based elucidation and designing of potential inhibitors against Plasmodium falciparum to target importin α/β mediated nuclear importation
Arafat Rahman Oany et al.
INFECTION GENETICS AND EVOLUTION (2021)
Drug design and repurposing with DockThor-VS web server focusing on SARS-CoV-2 therapeutic targets and their non-synonym variants
Isabella A. Guedes et al.
SCIENTIFIC REPORTS (2021)
Essential oils as an effective alternative for the treatment of COVID-19: Molecular interaction analysis of protease (Mpro) with pharmacokinetics and toxicological properties
Sukanya Panikar et al.
JOURNAL OF INFECTION AND PUBLIC HEALTH (2021)
Structural Basis of Potential Inhibitors Targeting SARS-CoV-2 Main Protease
Hylemariam Mihiretie Mengist et al.
FRONTIERS IN CHEMISTRY (2021)
Computational investigations of three main drugs and their comparison with synthesized compounds as potent inhibitors of SARS-CoV-2 main protease (Mpro): DFT, QSAR, molecular docking, and in silico toxicity analysis
Ranjan K. Mohapatra et al.
JOURNAL OF KING SAUD UNIVERSITY SCIENCE (2021)
Exploring the binding efficacy of ivermectin against the key proteins of SARS-CoV-2 pathogenesis: an in silico approach
Abhigyan Choudhury et al.
FUTURE VIROLOGY (2021)
Molecular dynamics analysis of phytochemicals from Ageratina adenophora against COVID-19 main protease (Mpro) and human angiotensin-converting enzyme 2 (ACE2)
Netra Prasad Neupane et al.
BIOCATALYSIS AND AGRICULTURAL BIOTECHNOLOGY (2021)
Highly Flexible Ligand Docking: Benchmarking of the DockThor Program on the LEADS-PEP Protein-Peptide Data Set
Karina B. Santos et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2020)
Comparative study of the interactions between fungal transcription factor nuclear localization sequences with mammalian and fungal importin-alpha
Natalia E. Bernardes et al.
SCIENTIFIC REPORTS (2020)
Glecaprevir and Maraviroc are high-affinity inhibitors of SARS-CoV-2 main protease: possible implication in COVID-19 therapy
Anas Shamsi et al.
BIOSCIENCE REPORTS (2020)
The Approved Dose of Ivermectin Alone is not the Ideal Dose for the Treatment of COVID-19
Virginia D. Schmith et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2020)
Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors
Linlin Zhang et al.
SCIENCE (2020)
Targeting the Dimerization of the Main Protease of Coronaviruses: A Potential Broad-Spectrum Therapeutic Strategy
Bhupesh Goyal et al.
ACS COMBINATORIAL SCIENCE (2020)
A SARS-CoV-2 protein interaction map reveals targets for drug repurposing
David E. Gordon et al.
NATURE (2020)
Anti-parasite drug ivermectin can suppress ovarian cancer by regulating lncRNA-EIF4A3-mRNA axes
Na Li et al.
EPMA JOURNAL (2020)
webPSN v2.0: a webserver to infer fingerprints of structural communication in biomacromolecules
Angelo Felline et al.
NUCLEIC ACIDS RESEARCH (2020)
Ivermectin and COVID-19: A report in Antiviral Research, widespread interest, an FDA warning, two letters to the editor and the authors' responses
Craig R. Rayner et al.
ANTIVIRAL RESEARCH (2020)
The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro
Leon Caly et al.
ANTIVIRAL RESEARCH (2020)
Webina: an open-source library and web app that runs AutoDock Vina entirely in the web browser
Yuri Kochnev et al.
BIOINFORMATICS (2020)
Ivermectin: a systematic review from antiviral effects to COVID-19 complementary regimen
Fatemeh Heidary et al.
JOURNAL OF ANTIBIOTICS (2020)
Interdiction of Protein Folding for Therapeutic Drug Development in SARS CoV-2
Fernando Bergasa-Caceres et al.
JOURNAL OF PHYSICAL CHEMISTRY B (2020)
Virtual screening and repurposing of FDA approved drugs against COVID-19 main protease
Mahmoud Kandeel et al.
LIFE SCIENCES (2020)
Identify potent SARS-CoV-2 main protease inhibitors via accelerated free energy perturbation-based virtual screening of existing drugs
Zhe Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Design, synthesis, characterization, computational study and in-vitro antioxidant and anti-inflammatory activities of few novel 6-aryl substituted pyrimidine azo dyes
Aziz Unnisa et al.
ARABIAN JOURNAL OF CHEMISTRY (2020)
The Role of Protein Disorder in Nuclear Transport and in Its Subversion by Viruses
Jacinta M. Wubben et al.
CELLS (2020)
Molecular docking and dynamic simulations of some medicinal plants compounds against SARS-CoV-2: an in silico study
Isaiah A. Adejoro et al.
JOURNAL OF TAIBAH UNIVERSITY FOR SCIENCE (2020)
myPresto/omegagene 2020: a molecular dynamics simulation engine for virtual-system coupled sampling
Kota Kasahara et al.
BIOPHYSICS AND PHYSICOBIOLOGY (2020)
In silico structure modelling of SARS-CoV-2 Nsp13 helicase and Nsp14 and repurposing of FDA approved antiviral drugs as dual inhibitors
Arun Bahadur Gurung
GENE REPORTS (2020)
Structure and inhibition of the SARS-CoV-2 main protease reveal strategy for developing dual inhibitors against Mpro and cathepsin L
Michael Dominic Sacco et al.
SCIENCE ADVANCES (2020)
Can Non-steroidal Anti-inflammatory Drugs Affect the Interaction Between Receptor Binding Domain of SARS-COV-2 Spike and the Human ACE2 Receptor? A Computational Biophysical Study
Lenin A. Gonzalez-Paz et al.
FRONTIERS IN PHYSICS (2020)
In silico molecular docking analysis for repurposing therapeutics against multiple proteins from SARS-CoV-2
Rujuta R. Deshpande et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2020)
Exploring the SARS-CoV-2 Proteome in the Search of Potential Inhibitors via Structure-Based Pharmacophore Modeling/Docking Approach
Giulia Culletta et al.
COMPUTATION (2020)
Ilimaquinone (marine sponge metabolite) as a novel inhibitor of SARS-CoV-2 key target proteins in comparison with suggested COVID-19 drugs: designing, docking and molecular dynamics simulation study
Malvi Surti et al.
RSC ADVANCES (2020)
Ivermectin as a potential COVID-19 treatment from the pharmacokinetic point of view: antiviral levels are not likely attainable with known dosing regimens
Georgi Momekov et al.
BIOTECHNOLOGY & BIOTECHNOLOGICAL EQUIPMENT (2020)
Antiviral Activity of Ivermectin Against SARS-CoV-2: An Old-Fashioned Dog with a New Trick-A Literature Review
Mudatsir Mudatsir et al.
SCIENTIA PHARMACEUTICA (2020)
Impact of Molecular Crowding on Translational Mobility and Conformational Properties of Biological Macromolecules
Niklas O. Junker et al.
JOURNAL OF PHYSICAL CHEMISTRY B (2019)
Can We Still Trust Docking Results? An Extension of the Applicability of DockBench on PDBbind Database
Giovanni Bolcato et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
The Binding Mechanisms and Inhibitory Effect of Intravenous Anesthetics on AChE In Vitro and In Vivo: Kinetic Analysis and Molecular Docking
Mesut Isik
NEUROCHEMICAL RESEARCH (2019)
Contribution of the residue at position 4 within classical nuclear localization signals to modulating interaction with importins and nuclear targeting
Kate M. Smith et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2018)
HullRad: Fast Calculations of Folded and Disordered Protein and Nucleic Acid Hydrodynamic Properties
Patrick J. Fleming et al.
BIOPHYSICAL JOURNAL (2018)
COACH-D: improved protein-ligand binding sites prediction with refined ligand-binding poses through molecular docking
Qi Wu et al.
NUCLEIC ACIDS RESEARCH (2018)
Prediction of Drug-Target Binding Kinetics by Comparative Binding Energy Analysis
Gaurav K. Ganotra et al.
ACS MEDICINAL CHEMISTRY LETTERS (2018)
SMPBS: Web Server for Computing Biomolecular Electrostatics Using Finite Element Solvers of Size Modified Poisson-Boltzmann Equation
Yang Xie et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2017)
Ivermectin - Old Drug, New Tricks?
Roz Laing et al.
TRENDS IN PARASITOLOGY (2017)
DINC 2.0: A New Protein-Peptide Docking Webserver Using an Incremental Approach
Dinler A. Antunes et al.
CANCER RESEARCH (2017)
CSM-lig: a web server for assessing and comparing protein-small molecule affinities
Douglas E. V. Pires et al.
NUCLEIC ACIDS RESEARCH (2016)
MD Simulations and FRET Reveal an Environment-Sensitive Conformational Plasticity of Importin-β
Kangkan Halder et al.
BIOPHYSICAL JOURNAL (2015)
PockDrug-Server: a new web server for predicting pocket druggability on holo and apo proteins
Hiba Abi Hussein et al.
NUCLEIC ACIDS RESEARCH (2015)
Molecular-crowding effects on single-molecule RNA folding/unfolding thermodynamics and kinetics
Nicholas F. Dupuis et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Mechanism for controlling the monomer-dimer conversion of SARS coronavirus main protease
Cheng-Guo Wu et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2013)
Search for invisible binding sites of low-molecular-weight compounds on protein molecules and prediction of inhibitory activity
M. E. Popov et al.
MOLECULAR BIOLOGY (2013)
History of Avermectin and Ivermectin, with Notes on the History of Other Macrocyclic Lactone Antiparasitic Agents
William C. Campbell
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2012)
Ivermectin is a potent inhibitor of flavivirus replication specifically targeting NS3 helicase activity: new prospects for an old drug
Eloise Mastrangelo et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)
Dimethyl sulfoxide induced structural transformations and non-monotonic concentration dependence of conformational fluctuation around active site of lysozyme
Susmita Roy et al.
JOURNAL OF CHEMICAL PHYSICS (2012)
NMSim Web Server: integrated approach for normal mode-based geometric simulations of biologically relevant conformational transitions in proteins
Dennis M. Krueger et al.
NUCLEIC ACIDS RESEARCH (2012)
An interaction-motif-based scoring function for protein-ligand docking
Zhong-Ru Xie et al.
BMC BIOINFORMATICS (2010)
IC50-to-Ki: a web-based tool for converting IC50 to Ki values for inhibitors of enzyme activity and ligand binding
R. Z. Cer et al.
NUCLEIC ACIDS RESEARCH (2009)
Correlation between dissociation and catalysis of SARS-CoV main protease
Pei-Ying Lin et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2008)
Mechanism for controlling the dimer-monomer switch and coupling dimerization to catalysis of the severe acute respiratory syndrome coronavirus 3C-like protease
Jiahai Shi et al.
JOURNAL OF VIROLOGY (2008)
An intuitive look at the relationship of Ki and IC50:: A more general use for the Dixon plot
BT Burlingham et al.
JOURNAL OF CHEMICAL EDUCATION (2003)
Potential of mean force for protein-protein interaction studies
L Jiang et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2002)
Share Paper
